MEDULLOBLASTOMA, NON-WNT/NON-SHH

Clinical trials for MEDULLOBLASTOMA, NON-WNT/NON-SHH explained in plain language.

Never miss a new study

Get alerted when new MEDULLOBLASTOMA, NON-WNT/NON-SHH trials appear

Sign up with your email to follow new studies for MEDULLOBLASTOMA, NON-WNT/NON-SHH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Heart drug tested as new hope for kids with recurrent brain cancer

Disease control Recruiting now

This study is testing if digoxin, a medication commonly used for heart conditions, can help control a rare and aggressive brain cancer called medulloblastoma when it has come back after initial treatment. It will involve about 23 children and young adults (ages 1-30) whose cancer…

Matched conditions: MEDULLOBLASTOMA, NON-WNT/NON-SHH

Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

MEDULLOBLASTOMA, NON-WNT/NON-SHH

Get alerted when new MEDULLOBLASTOMA, NON-WNT/NON-SHH trials appear

Heart drug tested as new hope for kids with recurrent brain cancer